NeuroPace announced today that it raised $67 million for its RNS system for treating refractory focal epilepsy. Accelmed Partners led the round, while an unnamed strategic investor, Revelation Partners, Soleus Capital and returning investors KCK Group and OrbiMed Advisors also participated, according to a news release. Mountain View, Calif-based NeuroPace’s financing includes $33 million in […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Sanofi to acquire MS drug-development partner for $3.68B
Sanofi (NYSE:SNY) announced today that it agreed to acquire all outstanding shares of Principia Biopharma (NSDQ:PRNB) in a deal worth approximately $3.68 billion. The deal sets all outstanding shares of Principia at $100 per share, which will be acquired in cash. Sanofi and Principia both received unanimous approval from their respective boards of directors, according to […]
FDA clears RapidAI blood clot detector
RapidAI announced today that it received FDA clearance for its Rapid LVO system for detecting suspected large vessel occlusions (LVOs). Menlo Park, Calif.-based RapidAI’s Rapid LVO is designed to help physicians speed up triage or transfer decision making. The system uses a vessel tracker, along with an assessment of brain regions with reduced blood vessel […]
MagVenture wins FDA clearance for OCD TMS treatment device
MagVenture announced that it received FDA clearance for its TMS Therapy for adjunct treatment of obsessive-compulsive disorder (OCD). Alpharetta-Ga.-based MagVenture said in a news release that the authorization is its second from the FDA, having already been cleared for its treatment of major depressive disorder. TMS Therapy uses magnetic pulses to stimulate a specific area […]
Neurolief wins FDA breakthrough nod for wearable neuromod for depression
Neurolief announced today that it received FDA breakthrough device designation for its Relivion DP system for treating major depression. Relivion is a wearable, non-invasive, multi-channel brain neuromodulation device designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who haven’t experienced satisfactory improvement from antidepressant medications, according to a news […]
Axonics beats on Q2 earnings despite losses
Axonics Modulation Technologies (NSDQ:AXNX) shares dipped slightly today on second-quarter results that beat the consensus earnings forecast. The Irvine, Calif.-based sacral neuromodulation (SNM) device maker posted losses of -$19.8 million, or -54¢ per share, on sales of $15.1 million for the three months ended June 30, 2020, for a -3.8% bottom-line slide on massive sales growth […]
Cerus Endovascular and Balt partnered to deliver Contour Neurovascular System in Germany
Cerus Endovascular and Balt this week announced a strategic distribution agreement to provide AB Medica with the exclusive rights to market and sell the Countour Neurovascular System and the Neqstent Coil Assisted Flow Diverter devices. The distribution agreement is currently limited to Germany. The financial details of the deal were not disclosed. “Our partnership with […]
Medtronic launches InterStim neurostim leads in U.S.
Medtronic (NYSE:MDT) today said it has launched its InterStim Micro neurostimulator in the U.S. The sacral neuromodulation therapy was FDA approved earlier this week and received CE mark approval in January. InterStim Micro is a neurostimulator that sends electrical impulses to the sacral nerves in the lower back to improve bladder and bowel control. The therapy […]
Neuronetics rises on Street-beating Q2
Neuronetics (NSDQ:STIM) shares ticked up today on second-quarter losses that managed to top the consensus forecast. The Malvern, Pa.-based psychiatric disorder treatment developer posted losses of $-7.8 million, or -41¢ per share, on sales of $9.7 million for the three months ended June 30, 2020, for a -9.5% bottom-line slide on a sales decline of -41.2%. […]
Stryker brain aneurysm stent wins expanded indication for posterior use
Stryker (NYSE:SYK) recently announced its Neuroform Atlas Stent System received expanded indication from the FDA. The Neuroform Atlas Stent System is now approved for use in the posterior circulation. With the approval, the company said long term treatment is more feasible with the device. Prior to the new indication, the stent system was approved for use […]
FDA approves new Medtronic neurostim leads
Medtronic (NYSE:MDT) announced today that it received FDA approval for its InterStim Micro neurostimulator and SureScan MRI leads. Fridley, Minn.-based Medtronic’s InterStim Micro device for delivering sacral neuromodulation (SNM) therapy is used in treating overactive bladder, fecal incontinence and non-obstructive urinary retention. According to a news release, it is the smallest rechargeable device of its kind. […]